Pasar al contenido principal

ESTUDIO DE ALTERACIONES EN EMBRIOGENESIS Y FECUNDACION QUE AFECTAN A LA EFICACIA REPRODUCTIVA DE ANIMALES DE GRANJA

PID2020-117501RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Effect of a truncated mutant factor V on hemostatic function and embryonic development in mice

  • Miguel Batuecas, Andrea
  • De Pablo Moreno, Juan Andrés
  • Porras, Néstor
  • Bermejo Álvarez, Pablo
  • González-Brusi, Leopoldo
  • Serrano, Luis J.
  • De Pablo-Moreno, Javier M.
  • Sánchez, María José
  • García-Arranz, Mariano
  • Rodríguez Bertos, Antonio Manuel
  • Chumappumkal, Bilgimol Joseph
  • Revuelta Rueda, Luis
  • Liras Martín, Antonio
Factor V is an essential protein in the blood clotting process and plays a central role in secondary hemostasis. Its deficiency causes a rare inherited disorder characterized by episodes of severe bleeding, some of which can be life-threatening. Although previous studies have established that factor V is essential for normal embryonic development, its specific contribution to vascular maturation remains incompletely understood, factor V is believed to contribute to blood vessel stabilization and regulate angiogenesis through its interaction with thrombin. In a recent study, a CRISPR-engineered mouse model intended to produced a mild factor V deficiency disease, unexpectedly produced a frameshift mutation in the A3 domain, resulting in a truncated protein. Factor V levels in healthy embryonic mouse tissues were assessed to investigate its role at different developmental stages. The mutation markedly impaired viability, as homozygous mice exhibited a lethal phenotype with severe bleeding and perinatal death, along with impaired coagulation function. Histopathological and immunohistochemical analyses indicated a link between factor V deficiency, thrombin and α-smooth muscle actin, potentially affecting proangiogenic signaling and embryonic vascular formation. Factor V gene expression increased during late embryogenesis, underscoring its importance in vascular development and maturation. Overall, these findings are consistent with a role for factor V in stabilizing embryonic blood vessels and modulating thrombin-dependent angiogenesis, and add further detail on the developmental impact of its deficiency and the pathogenesis of congenital bleeding disorders.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

RNA-sequencing reveals genes linked with oocyte developmental potential in bovine cumulus cells

  • Martínez-Moro, Álvaro
  • González-Brusi, Leopoldo
  • Lamas-Toranzo, Ismael
  • O'Callaghan, Elena
  • Esteve-Codina, Anna
  • Lonergan, Pat
  • Bermejo-Álvarez, Pablo
Cumulus cells provide an interesting biological material to perform analyses to understand the molecular clues determining oocyte competence. The objective of this study was to analyze the transcriptional differences between cumulus cells from oocytes exhibiting different developmental potentials following individual in vitro embryo production by RNA-seq. Cumulus cells were allocated into three groups according to the developmental potential of the oocyte following fertilization: (1) oocytes developing to blastocysts (Bl+), (2) oocytes cleaving but arresting development before the blastocyst stage (Bl-), and (3) oocytes not cleaving (Cl-). RNAseq was performed on 4 (Cl-) or 5 samples (Bl+ and Bl-) of cumulus cells pooled from 10 cumulus-oocyte complexes per group. A total of 49, 50, and 18 differentially expressed genes (DEGs) were detected in the comparisons Bl+ versus Bl-, Bl+ versus Cl- and Bl- versus Cl-, respectively, showing a fold change greater than 1.5 at an adjusted p value <0.05. Focussing on DEGs in cumulus cells from Bl+ group, 10 DEGs were common to both comparisons (10/49 from Bl+ vs. Bl-, 10/50 from Bl+ vs. Cl-). These DEGs correspond to 6 upregulated genes (HBE1, ITGA1, PAPPA, AKAP12, ITGA5, and SLC1A4), and 4 downregulated genes (GSTA1, PSMB8, FMOD, and SFRP4) in Bl+ compared to the other groups, from which 7 were validated by quantitative PCR (HBE1, ITGA1, PAPPA, AKAP12, ITGA5, PSMB8 and SFRP4). These genes are involved in critical biological functions such as integrin-mediated cell adhesion, oxygen availability, IGF and Wnt signaling or PKA pathway, highlighting specific biological processes altered in incompetent in vitro maturation oocytes., This work was funded by the projects IND2017/BIO-7748 from Madrid Region Government and AGL2017-84908-R and PID2020-117501RB-I00 by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO). AMM was funded by project IND2017/BIO-7748 and ILT by a FPI fellowship by MINECO.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

RNA-sequencing reveals genes linked with oocyte developmental potential in bovine cumulus cells

  • Martínez-Moro, Álvaro
  • González-Brusi, Leopoldo
  • Lamas Toranzo, Ismael
  • O'Callaghan, Elena
  • Esteve-Codina, Anna
  • Lonergan, P.
  • Bermejo Álvarez, Pablo
Cumulus cells provide an interesting biological material to perform analyses to understand the molecular clues determining oocyte competence. The objective of this study was to analyze the transcriptional differences between cumulus cells from oocytes exhibiting different developmental potentials following individual in vitro embryo production by RNA-seq. Cumulus cells were allocated into three groups according to the developmental potential of the oocyte following fertilization: (1) oocytes developing to blastocysts (Bl+), (2) oocytes cleaving but arresting development before the blastocyst stage (Bl-), and (3) oocytes not cleaving (Cl-). RNAseq was performed on 4 (Cl-) or 5 samples (Bl+ and Bl-) of cumulus cells pooled from 10 cumulus-oocyte complexes per group. A total of 49, 50, and 18 differentially expressed genes (DEGs) were detected in the comparisons Bl+ versus Bl-, Bl+ versus Cl- and Bl- versus Cl-, respectively, showing a fold change greater than 1.5 at an adjusted p value <0.05. Focussing on DEGs in cumulus cells from Bl+ group, 10 DEGs were common to both comparisons (10/49 from Bl+ vs. Bl-, 10/50 from Bl+ vs. Cl-). These DEGs correspond to 6 upregulated genes (HBE1, ITGA1, PAPPA, AKAP12, ITGA5, and SLC1A4), and 4 downregulated genes (GSTA1, PSMB8, FMOD, and SFRP4) in Bl+ compared to the other groups, from which 7 were validated by quantitative PCR (HBE1, ITGA1, PAPPA, AKAP12, ITGA5, PSMB8 and SFRP4). These genes are involved in critical biological functions such as integrin-mediated cell adhesion, oxygen availability, IGF and Wnt signaling or PKA pathway, highlighting specific biological processes altered in incompetent in vitro maturation oocytes., This work was funded by the projects IND2017/BIO‐7748 from Madrid Region Government and AGL2017‐84908‐R and PID2020‐117501RB‐I00 by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO). AMM was funded by project IND2017/BIO‐7748 and ILT by a FPI fellowship by MINECO., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antitumor applications of polyphenol-conjugated turnip mosaic virus-derived nanoparticles

  • Velázquez-Lam, Edith
  • Tome-Amat, Jaime
  • Segrelles, C.
  • Yuste-Calvo, C.
  • Asensio, S.
  • Peral, J.
  • Ponz Ascaso, Fernando
  • Lorz, C.
Filamentous plant virus-derived nanoparticles are biodegradable and noninfectious to humans. Their structure is also amenable to chemical modifications. They constitute an appealing material for biomedical applications including imaging and drug delivery. We had previously used turnip mosaic virus-derived nanoparticles (TuMV-NPs) to increase antibody-sensing in vivo, to prevent biofilm formation and to build biological nanoscaffolds. Materials & methods: We analyzed TuMV-NP biodistribution and tumor homing using in vivo imaging. We studied in vitro the interaction with human cancer cell lines and the antiproliferative effect of epigallocatechin gallate-functionalized TuMV-NPs. Results & conclusion: TuMV-NPs are efficiently internalized by human cells and show good tumor homing. The antiproliferative effect of epigallocatechin gallate-TuMV-NPs suggests that they could offer a potential anticancer therapy., This work was funded by the projects IND2017/BIO‐7748 from Madrid Region Government and AGL2017‐84908‐R and PID2020‐117501RB‐I00 by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO). AMM was funded by project IND2017/BIO‐7748 and ILT by a FPI fellowship by MINECO., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pre-hatching exposure to N2B27 medium improves post-hatching development of bovine embryos in vitro

  • Ramos Ibeas, Priscila
  • Pérez-Gómez, Alba
  • González-Brusi, Leopoldo
  • Quiroga, Alejandra C.
  • Bermejo Álvarez, Pablo
4 Pág., Ungulate embryos undergo critical cell differentiation and proliferation events around and after blastocyst hatching. Failures in these processes lead to early pregnancy losses, which generate an important economic impact on farming. Conventional embryo culture media, such as SOF, are unable to support embryo development beyond hatching. In contrast, N2B27 medium supports early post-hatching development, evidencing a swift in embryonic nutritional requirements during this developmental window. Here, we investigate if earlier exposure to N2B27 could improve embryo development after hatching. Embryo culture in N2B27 from day (D) 5, 6 or 7 significantly enhanced complete hypoblast migration (>45 vs. ∼24%) and epiblast development into an embryonic disc (ED)-like structure at D12 (>40 vs. 23%), compared to embryos cultured in SOF up to D9. Culture in N2B27 from D5 significantly increased epiblast and hypoblast cell number in D8 blastocysts, but post-hatching embryos cultured in N2B27 from D5 or 6 frequently showed a disorganized distribution of epiblast cells. In conclusion, bovine embryo culture in N2B27 from D7 onwards improves subsequent post-hatching development. This improved fully in vitro system will be very useful to functionally explore cell differentiation mechanisms and the bases of early pregnancy failures without requiring animal experimentation., This work has been funded by the projects StG-757886-ELONGAN from the European Research Council and PID2020-117501RB-I00 and ECQ2018-005184-P from the Spanish Ministry of Science and Innovation to PBA, and by the project PID2021-122153NA-I00 from the Spanish Ministry of Science and Innovation to PRI., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The human cumulus cell transcriptome provides poor predictive value for embryo transfer outcome

  • Martínez-Moro, Álvaro
  • González-Brusi, Leopoldo
  • Lamas Toranzo, Ismael
  • González-Dosal, Pilar
  • Rodríguez-Juárez, Félix
  • Bermejo Álvarez, Pablo
9 Pág., Is the transcriptome of cumulus cells a good predictor of the embryo's developmental competence?, This work was funded by the projects IND2017/BIO-7748 from the Madrid Region Government, and AGL2017-84908-R and PID2020-117501RB-I00 from the Spanish Ministry of Economy, Industry and Competitiveness (MINECO). A.M.-M. was funded by project IND2017/BIO-7748, and I.L.-T. by an FPI fellowship by MINECO., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Efficient and repeatable in vitro fertilization in rabbits

  • Hamzé, Julieta G.
  • Peris-Frau, Patricia
  • Galiano-Cogolludo, Beatriz
  • Tomás-Almenar, Cristina
  • Santiago-Moreno, Julián
  • Bermejo Álvarez, Pablo
8 Pág., Rabbits constitute an interesting model to understand gamete interaction and test novel Artificial Reproductive Techniques, but in vitro fertilization (IVF) is particularly problematic in this species. We have conducted a series of experiments to develop a consistent IVF technique. Initially, we checked viability, acrosome integrity, capacitation and motility in ejaculated sperm purified by a density gradient and incubated at different times in three different media: Tyrode's Albumin Lactate Pyruvate (TALP), human tubal fluid (HTF), and Brackett and Oliphant (BO). Total and progressive motility at 10-24 h and linearity from 3 h onwards was significantly higher in BO medium compared to TALP and HTF. Subsequently, cumulus-oocyte complexes (COCs) collected 10 h after induction of ovulation were incubated with sperm in TALP, HTF or BO for 18 h with or without performing sperm pre-incubation for 6 h. Pronuclear formation rate at 18 h was significantly higher in BO compared to other media (∼84 % vs. 17-22 %) and was not improved by pre-incubation. As COCs recovery rate was low at 10 h after induction of ovulation, COCs were collected at 12 h and co-incubated with sperm in BO. Pronuclear formation rate was similar than those obtained in COCs collected at 10 h (∼85 %), and when embryos were allowed to develop in vitro, the protocol yielded high cleavage and blastocyst rates (91 and 59 %, respectively). In conclusion, ejaculated rabbit sperm purified in a density gradient fertilize efficiently COCs collected at 12 h in BO medium., Supported by projects PID2020-117501RB-I00 from MINECO and European Union - NextGenerationEU (Margarita Salas postdoctoral grant, Ministerio de Universidades of the Government of Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effect of arachidonic acid on pre- and post-hatching in vitro bovine embryo development

  • González-Brusi, Leopoldo
  • Pérez-Gómez, Alba
  • Quiroga, Alejandra C.
  • Tamargo, Carolina
  • Ramos Ibeas, Priscila
  • Bermejo Álvarez, Pablo
8 Pág., Arachidonic acid (AA) is the precursor of prostaglandins, which may play autocrine roles during early embryo development., This work was supported by the projects StG-757886-ELONGAN from the European Research Council and AGL2017-84908-R, PID2020-117501RB-I00 and ECQ2018-005184-P from the Spanish Ministry of Science and Innovation to PBA, and PID2021-122153NA-I00 from the Spanish Ministry of Science and Innovation to PRI., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SMC2 ablation impairs bovine embryo development shortly after blastocyst hatching

  • Pérez-Gómez, Alba
  • Flores-Borobia, Inés
  • Hamzé, Julieta G.
  • Galiano-Cogolludo, Beatriz
  • Lamas Toranzo, Ismael
  • González-Brusi, Leopoldo
  • Ramos Ibeas, Priscila
  • Bermejo Álvarez, Pablo
10 Pág., Bovine embryos lacking SMC2 (a core component of condensins I and II) are unable to survive maternal recognition of pregnancy. SMC2 KO embryos are able to form blastocysts, exhibiting a reduced cell proliferation ability, and arrest their development shortly after hatching., This work was supported by the projects StG-757886-ELONGAN from the European Research Council and PID2020-11750RB-I00 and ECQ2018-005184-P from the Spanish Ministry of Science and Innovation to PBA, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The role of TEAD4 in trophectoderm commitment and development is not conserved in non-rodent mammals

  • Pérez-Gómez, Alba
  • González-Brusi, Leopoldo
  • Flores-Borobia, Inés
  • Galiano-Cogolludo, Beatriz
  • Lamas Toranzo, Ismael
  • Hamzé, Julieta G.
  • Toledano-Díaz, Adolfo
  • Santiago-Moreno, Julián
  • Ramos Ibeas, Priscila
  • Bermejo Álvarez, Pablo
The first lineage differentiation in mammals gives rise to the inner cell mass and the trophectoderm (TE). In mice, TEAD4 is a master regulator of TE commitment, as it regulates the expression of other TE-specific genes and its ablation prevents blastocyst formation, but its role in other mammals remains unclear. Herein, we have observed that TEAD4 ablation in two phylogenetically distant species (bovine and rabbit) does not impede TE differentiation, blastocyst formation and the expression of TE markers, such as GATA3 and CDX2, although a reduced number of cells in the inner cell mass was observed in bovine TEAD4 knockout (KO) blastocysts. Transcriptional analysis in bovine blastocysts revealed no major transcriptional effect of the ablation, although the expression of hypoblast and Hippo signalling-related genes tended to be decreased in KO embryos. Experiments were conducted in the bovine model to determine whether TEAD4 was required for post-hatching development. TEAD4 KO spherical conceptuses showed normal development of the embryonic disc and TE, but hypoblast migration rate was reduced. At later stages of development (tubular conceptuses), no differences were observed between KO and wild-type conceptuses., This work was funded by the European Research Council (StG-757886ELONGAN), the Ministerio de Ciencia e Innovacion (PID2020-117501RB-I00 and ECQ2018-005184-P to P.B.-A.; PID2021-122153NA-I00 to P.R.-I.) and a Margarita Salas postdoctoral grant from the Ministerio de Universidades (to J.G.H.). Open access funding provided by Consejo Superior de Investigaciones Cientıficas. Deposited in PMC for immediate release., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development of a novel and viable knock-in factor V deficiency murine model: Utility for an ultra-rare disease

  • Pablo Moreno, Juan Andrés de
  • González-Brusi, Leopoldo
  • Miguel Batuecas, Andrea
  • Bermejo-Álvarez, Pablo
  • Revuelta Rueda, Luis
  • Liras Martin, Antonio
Factor V deficiency is a congenital coagulation disorder characterized by the absence or malfunction of factor V (FV). The purpose of this study was to develop a viable FV-deficient mouse model using CRISPR/Cas9 technology. A viable pathological model of the disease was not available to develop new therapies. A previous in silico study was performed to select a mutation causing a mild disease phenotype in humans (Thr1898Met missense). Such mutation was replicated in mice by CRISPR-mediated homology directed repair. Following crossing, homozygous individuals were subjected to coagulometry assays, including FV levels, prothrombin time (PT), and activated partial thromboplastin time (aPTT). The in silico study suggested that the mutation destabilizes FV structure of both mouse and human variants, putatively producing a mild phenotype of the disease in mice. Mendelian inheritance was observed in the offspring. No spontaneous signs of blood clotting disturbances, premature deaths or gestational dysfunctions were observed. FV levels in homozygous animals were 24.5% ± 5.1; 39.7 sec ± 2.8; PT was 61.8% ± 6.3; 23.4 sec ± 1.6 (INR = 1.47 ± 0.12); and aPTT was 46.9 sec ± 3.2. A viable FV-deficient mouse model was generated by introducing a missense mutation in FV. The model exhibits a mild phenotype of the disease, akin to that observed in humans., AMB received a predoctoral contract from the Community of Madrid, grant number CT85/23; AL received funding for the development of this research from the Association for Research and Cure of Factor V deficiency (ASDEFAV), grant number ASDEFAV/2021-24 (https://unaesperanzaparacelia.org/); JADPM received a predoctoral contract from the Complutense University of Madrid and Banco Santander, grant number CT63/19-CT64/19 (https://www.ucm.es/ct63-19-ct64-19), and PBA received funding for the development of this research from the Spanish Ministry of Science and Innovation, grant number PID2020-117501RB-I00 (https://www.ciencia.gob.es/en/)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Coagulation factor V deficiency. From mutation to "cure" by advanced therapies, Déficit de factor V de la coagulación. De la mutación a la «curación» mediante terapias avanzadas

  • Liras, Antonio
  • Bernal, Sara
  • Serrano, Luis J.
  • Bermejo Álvarez, Pablo
  • Miguel Batuecas, Andrea
  • García-Olmo, Damián
  • García-Arranz, Mariano
  • García-Bravo, María
  • Segovia, José Carlos
  • González-Brusi, Leopoldo
  • De Pablo-Moreno, Javier M.
  • Rodríguez-Bertos, Antonio
  • García-Torralba, A.
  • Extremera, Mª José
  • Camero, Mª Dolores
  • Revuelta, Luis
  • Pablo Moreno, Juan Andrés de
Trabajo ganador del Premio RANF 2024 en el Concurso Científico de la Real Academia Nacional de Farmacia., [EN] This work represents a retrospective and updated review in a scientific context of itself, the Advanced Therapies group of the Complutense University of Madrid. The project, which began almost 7 years ago, has pursued the establishment of gene and cell therapy protocols for the treatment of coagulation factor V deficiency. This “trip” has been possible thanks to the Association for the Research and Cure of Factor V Deficiency, A Hope for Celia, through micro sponsorship or crowdfunding and through predoctoral contracts granted by the Complutense University of Madrid. The results obtained and presented in the present work have been very successful for this ultra-rare disease. The project was initiated with the complete study of the mutational cause in a patient (Celia) and the study of her progenitor segregation; then, with the establishment of cellular and live animal models for the pathological mutation, using gene editing with CRISPR, the measurement of factor V in mice was standardized, and finally, the proof of concept of a gene therapy lentiviral protocol was demonstrated. All these results have given rise to several articles published in high-impact journals and two that are in the process of editorial review. Two patents have also been obtained on the correction of mutations in the F5 gene by gene editing and another on the viable animal model itself with factor V deficiency. All these results open the door to future approaches in the preclinical phase in animal models to establish the guarantees of efficacy and safety of the gene therapy protocol with lentiviral vectors., [ES] Este trabajo representa una revisión retrospectiva y actualizada en un contexto científico propio del grupo de Terapias Avanzadas de la Universidad Complutense de Madrid. El proyecto, que se inició hace ya casi siete años, ha perseguido el establecimiento de protocolos de terapia génica y celular para el tratamiento del déficit de factor V de la coagulación. Este recorrido ha sido posible gracias a la Asociación para la Investigación y Cura del Déficit de Factor V, Una Esperanza para Celia, a través de micro mecenazgo o financiación colectiva (crowdfunding), y a través de contratos predoctorales concedidos por la Universidad Complutense de Madrid. Los resultados obtenidos y que se exponen en el presente trabajo, han sido muy exitosos para esta enfermedad ultra rara. Se inició el proyecto con el estudio completo de la causa mutacional en una paciente (Celia) y el estudio de segregación de sus progenitores; después con el establecimiento de un modelo celular y en animal vivo para la mutación patológica, utilizando edición génica con CRISPR; se estandarizó la medida de factor V en ratón y, por último, se demostró la prueba de concepto de un protocolo de terapia génica lentiviral. Los resultados han dado lugar a varios artículos publicados en revistas de alto impacto y dos que se encuentran en proceso de revisión editorial. Dos patentes se han obtenido también, una sobre la corrección de mutaciones en el gen F5 mediante edición génica y otra del propio modelo animal viable con déficit de factor V. Todos estos resultados abren la puerta a futuros planteamientos, en fase preclínica en modelo animal patológico, con el fin de establecer las garantías de eficacia y seguridad del protocolo de terapia génica con vectores lentivirales., En las primeras etapas de la investigación fue la Asociación Andaluza de Hemofilia la que financió parte de la actividad científica (ASANHEMO FV2016–20). También participó en la financiación la empresa farmacéutica Octapharma S.A (OCPH2019-20). Posteriormente, y a través de una colaboración científica con la Fundación Jiménez Diaz y el Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) de Madrid, la financiación vino del Instituto de Salud Carlos III, de fondos para el Desarrollo Regional Europeo (RETICS RD 16/0011/00011 y RD 16/0011/0013), de la Dirección General de Investigación de la Comunidad de Madrid (AvanCell-CM; Ref. S2017/BMD-3692) y de la Agencia Estatal de Investigación (PID2020- 119637RB-I00). En los últimos tres años de investigación la financiación se recibió de la Universidad Complutense de Madrid a través de contratos predoctorales (CT63/19-CT64/19) y de la Asociación para la Investigación y Cura del Déficit de Factor V, Una Esperanza para Celia (ASDEFAV/2021-24). También, a través de la colaboración con el Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), los fondos aplicados fueron del Ministerio de Ciencia, Innovación y Universidades (PID2020-117501RB-I00). Agradecimiento especial a Benedicto Jerónimo, supervisor del animalario de la Facultad de Veterinaria de la Universidad Complutense de Madrid donde se llevaron a cabo los procedimientos, por preservar tan seriamente la seguridad y el bienestar de los animales. También agradecer al Centro de Asistencia a la Investigación, Unidad de Genómica, de la Universidad Complutense de Madrid, y a los doctores Enrique Páramo y Mónica Carballo, responsables del Servicio de Animalario y Cirugía Experimental del Hospital Nacional de Parapléjicos de Toledo, por su profesionalidad y facilidades ofrecidas para llevar a cabo todos los experimentos de terapia génica lentiviral. Agradecer, por último, a la Fundación Inocente, la ayuda concedida (FII2024-151) para el desarrollo de este proyecto., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

RNA-sequencing reveals genes linked with oocyte developmental potential in bovine cumulus cells

  • Martínez-Moro, Álvaro
  • González-Brusi, Leopoldo
  • Lamas-Toranzo, Ismael
  • O&apos;Callaghan, Elena
  • Esteve-Codina, Anna
  • Lonergan, Pat
  • Bermejo-Álvarez, Pablo
Cumulus cells provide an interesting biological material to perform analyses to understand the molecular clues determining oocyte competence. The objective of this study was to analyze the transcriptional differences between cumulus cells from oocytes exhibiting different developmental potentials following individual in vitro embryo production by RNA-seq. Cumulus cells were allocated into three groups according to the developmental potential of the oocyte following fertilization: (1) oocytes developing to blastocysts (Bl+), (2) oocytes cleaving but arresting development before the blastocyst stage (Bl-), and (3) oocytes not cleaving (Cl-). RNAseq was performed on 4 (Cl-) or 5 samples (Bl+ and Bl-) of cumulus cells pooled from 10 cumulus-oocyte complexes per group. A total of 49, 50, and 18 differentially expressed genes (DEGs) were detected in the comparisons Bl+ versus Bl-, Bl+ versus Cl- and Bl- versus Cl-, respectively, showing a fold change greater than 1.5 at an adjusted p value <0.05. Focussing on DEGs in cumulus cells from Bl+ group, 10 DEGs were common to both comparisons (10/49 from Bl+ vs. Bl-, 10/50 from Bl+ vs. Cl-). These DEGs correspond to 6 upregulated genes (HBE1, ITGA1, PAPPA, AKAP12, ITGA5, and SLC1A4), and 4 downregulated genes (GSTA1, PSMB8, FMOD, and SFRP4) in Bl+ compared to the other groups, from which 7 were validated by quantitative PCR (HBE1, ITGA1, PAPPA, AKAP12, ITGA5, PSMB8 and SFRP4). These genes are involved in critical biological functions such as integrin-mediated cell adhesion, oxygen availability, IGF and Wnt signaling or PKA pathway, highlighting specific biological processes altered in incompetent in vitro maturation oocytes., This work was funded by the projects IND2017/BIO-7748 from Madrid Region Government and AGL2017-84908-R and PID2020-117501RB-I00 by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO). AMM was funded by project IND2017/BIO-7748 and ILT by a FPI fellowship by MINECO.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Development of a novel and viable knock-in factor V deficiency murine model: Utility for an ultra-rare disease

  • De Pablo Moreno, Juan Andrés
  • González-Brusi, Leopoldo
  • Miguel Batuecas, Andrea
  • Bermejo Álvarez, Pablo
  • Revuelta Rueda, Luis
  • Liras Martín, Antonio
Factor V deficiency is a congenital coagulation disorder characterized by the absence or malfunction of factor V (FV). The purpose of this study was to develop a viable FV-deficient mouse model using CRISPR/Cas9 technology. A viable pathological model of the disease was not available to develop new therapies. A previous in silico study was performed to select a mutation causing a mild disease phenotype in humans (Thr1898Met missense). Such mutation was replicated in mice by CRISPR-mediated homology directed repair. Following crossing, homozygous individuals were subjected to coagulometry assays, including FV levels, prothrombin time (PT), and activated partial thromboplastin time (aPTT). The in silico study suggested that the mutation destabilizes FV structure of both mouse and human variants, putatively producing a mild phenotype of the disease in mice. Mendelian inheritance was observed in the offspring. No spontaneous signs of blood clotting disturbances, premature deaths or gestational dysfunctions were observed. FV levels in homozygous animals were 24.5% ± 5.1; 39.7 sec ± 2.8; PT was 61.8% ± 6.3; 23.4 sec ± 1.6 (INR = 1.47 ± 0.12); and aPTT was 46.9 sec ± 3.2. A viable FV-deficient mouse model was generated by introducing a missense mutation in FV. The model exhibits a mild phenotype of the disease, akin to that observed in humans.